Untangling fibril formation and dissociation in Parkinson's disease

November 30, 2016, Publicase Comunicação Científica
Immunohistochemistry for alpha-synuclein showing positive staining (brown) of an intraneural Lewy-body in the Substantia nigra in Parkinson's disease. Credit: Wikipedia

Prions are misfolded proteins. The complex three-dimensional structure of a prion's progenitor protein becomes altered, somehow causing it to malfunction. Worse, the malformation of these progenitor proteins into prions causes them to aggregate into amyloid plaques that can result in a disease state. Prions are responsible for protein-caused infectious neurodegenerative diseases like mad cow disease and scrapie in livestock.

More recently, the protein α-synuclein (α-syn) has been implicated as a prion progenitor. In its normal state, the protein is found at the presynaptic terminals of neurons, from which chemical signals called neurotransmitters are released from one neuron to the next or from a neuron to an organ or other tissue type. Specifically, α-syn is involved in dopamine transport within the nervous system. But when acting like a prion, α-syn fibrils aggregate in the neurons into irregular structures with hydrophobic cores called Lewy bodies. The latter has been implicated in the neurodegenerative motor system disorder Parkinson's disease (PD), including the autosomal-dominant form of PD that is associated with known genetic mutations A30P, A53T and E46K. Even though PD is considered a prion-like disease, no study has yet provided a clear picture of how pathogenic fibrils are formed and propagated in the brain of PD patients.

A team led by Jerson Lima Silva at the Federal University of Rio de Janeiro, Brazil, studied the structure of pathogenic α-syn fibril plaques and how they act at an atomic scale. In the study, published on November 30 in the journal Scientific Reports, the group shows how pressure breaks apart α-syn fibril, like those found in Lewy bodies, into monomers. The remaining fibrils carry different features than those found in normal α-synuclein.

Silva's group used high hydrostatic pressure (HHP), a process also used to preserve and sterilize food, using high-pressure water pumps. The technique has proven to be a useful laboratory tool because it can unfold a protein from its regular folded structure to allow it to return to its original form. The technique reveals all the steps in the process of protein folding and unfolding as though they were instructions for building an origami figure. Silva's team coupled HHP with nuclear magnetic resonance (NMR) spectroscopy to obtain, for the first time, a picture of what happens on an .

NMR showed that the HHP technique forced water within the hydrophobic core of normal α-synuclein fibrils, causing it to separate into dynamically modified monomers, which are hidden states not previously detected. The process of generating the monomers leaves a trail of slightly modified fibrils that are then capable of seeding α-syn aggregation, a biological phenomenon observed in prion diseases in which the abnormal form of a protein induces their normal counterpart to convert into their abnormal form. Interestingly, no oligomers, which are usually associated with toxic species in many , were detected. These are real breakthroughs, because although PD is considered a prion-like disease, this is the first evidence showing the neurotoxic seeding mechanism observed in PD.

By replicating the structural form of the protein found in the disease state and then reverting the protein back to its properly functioning configuration, Silva's team hopes to aid in the development of new strategies to treat Parkinson's disease. Specifically, the team believes the research may provide a way forward to block the formation of new α-synuclein aggregation and perhaps prevent it from even starting. Further, the work may be used to signal the beginnings of Parkinson's markers and thus be used in early diagnosis. "HHP is a potential tool for developing a new generation of target species and for drug screening studies," says Silva. Indeed, the study is the first to reveal the molecular details of how hydrophobic interaction and formation of water-excluded cavities can contribute to the assembly and stabilization of the fibrils in PD, an understanding that is crucial for developing new strategies to block the toxic species and neutralize fibril propagation in the brains of patients suffering from Parkinson's Disease.

Explore further: Mutant prion protein could help reveal neurodegenerative disease mechanisms

More information: Structural basis for the dissociation of α-synuclein fibrils triggered by pressure perturbation of the hydrophobic core, Scientific Reports, DOI: 10.1038/srep37990

Related Stories

Mutant prion protein could help reveal neurodegenerative disease mechanisms

November 23, 2016
For the first time, scientists have isolated a mutated prion protein that can multiply in the lab but not in living animals, according to a PLOS Pathogens study. The mutant prion provides new insights into the mechanisms ...

Tunneling nanotubes between neurons enable the spread of Parkinson's disease via lysosomes

August 22, 2016
Scientists from the Institut Pasteur have demonstrated the role of lysosomal vesicles in transporting α-synuclein aggregates, responsible for Parkinson's and other neurodegenerative diseases, between neurons. These proteins ...

Heparin might be the key to prevent prion conversion and disease

March 24, 2014
Prions are infectious agents responsible for neurodegenerative diseases such as bovine spongiform encephalitis (commonly known as "mad cow disease") and Creutzfeldt–Jakob disease in humans.

Newly discovered infectious prion structure shines light on mad cow disease

September 8, 2016
Groundbreaking research from the University of Alberta has identified the structure of the infectious prion protein, the cause of "mad cow disease" or BSE, chronic wasting disease in deer and elk and Creutzfeldt-Jakob disease ...

Tiny changes in Parkinson's protein can have 'dramatic' impact on processes behind onset

August 29, 2016
Specific mutations in the protein associated with Parkinson's Disease, in which just one of its 140 building blocks is altered, can make a dramatic difference to processes which may lead to the condition's onset, researchers ...

Closer look at proteins involved in Parkinson's disease reveals segment involved in amyloid formation

September 10, 2015
(Medical Xpress)—A team of scientists from several research centers in the U.S. has taken a closer look at α-synuclein, a protein that is abundant in the human brain, and which is also involved in the development of Parkinson's ...

Recommended for you

A new therapeutic avenue for Parkinson's disease

January 23, 2018
Systemic clearing of senescent astrocytes prevents Parkinson's neuropathology and associated symptoms in a mouse model of sporadic disease, the type implicated in 95% of human cases. Publishing in Cell Reports, researchers ...

Investigators eye new target for treating movement disorders

January 19, 2018
Blocking a nerve-cell receptor in part of the brain that coordinates movement could improve the treatment of Parkinson's disease, dyskinesia and other movement disorders, researchers at Vanderbilt University have reported.

Parkinson's disease 'jerking' side effect detected by algorithm

January 8, 2018
A mathematical algorithm that can reliably detect dyskinesia, the side effect from Parkinson's treatment that causes involuntary jerking movements and muscle spasms, could hold the key to improving treatment and for patients ...

New brainstem changes identified in Parkinson's disease

January 4, 2018
A pioneering study has found that patients with Parkinson's disease have more errors in the mitochondrial DNA within the brainstem, leading to increased cell death in that area.

Caffeine level in blood may help diagnose people with Parkinson's disease

January 3, 2018
Testing the level of caffeine in the blood may provide a simple way to aid the diagnosis of Parkinson's disease, according to a study published in the January 3, 2018, online issue of Neurology, the medical journal of the ...

Researchers shed light on why exercise slows progression of Parkinson's disease

December 22, 2017
While vigorous exercise on a treadmill has been shown to slow the progression of Parkinson's disease in patients, the molecular reasons behind it have remained a mystery.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.